Cargando…
Post-mastectomy radiotherapy benefits subgroups of breast cancer patients with T1–2 tumor and 1–3 axillary lymph node(s) metastasis
BACKGROUND: To determine the role of postmastectomy radiotherapy (PMRT) in breast cancer patients with T1–2 and N1 disease. PATIENTS AND METHODS. A total of 207 postmastectomy women were enrolled. The 5-year Kaplan-Meier estimates of locoregional recurrence rate (LRR), distant recurrence rate (DRR)...
Autores principales: | Su, Yu-Li, Li, Shan-Hsuan, Chen, Yen-Yang, Chen, Hui-Chun, Tang, Yen, Huang, Cheng-Hua, Chou, Fong-Fu, Wu, Shih-Chung, Rau, Kun-Ming |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Versita, Warsaw
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4110089/ https://www.ncbi.nlm.nih.gov/pubmed/25177247 http://dx.doi.org/10.2478/raon-2013-0085 |
Ejemplares similares
-
Omission of axillary lymph node dissection in patients who underwent total mastectomy with 1 or 2 metastatic lymph nodes
por: Kim, Bong Kyun, et al.
Publicado: (2020) -
Idiopathic Thrombocytopenic Purpura after Mastectomy and Axillary Lymph Node Dissection
por: Santivasi, Wil L., et al.
Publicado: (2014) -
Radiotherapy instead of axillary lymph node dissection: evaluation of axillary lymph node dose coverage with whole breast radiotherapy
por: Bukovszky, Bence, et al.
Publicado: (2022) -
Axillary sentinel lymph node biopsy after mastectomy: a case report
por: Vicente, Diego A, et al.
Publicado: (2010) -
Could axillary lymph node dissection be omitted in the mastectomy patient with tumor positive sentinel node?
por: You, Ji Young, et al.
Publicado: (2023)